Anika Therapeutics, Inc. — Earnings Release 2003

Nov 7, 2003

8-K 1 a03-4959_18k.htm 8-K

*SECURITIES AND EXCHANGE COMMISSION*

WASHINGTON, D.C. 20549

*FORM 8-K*

*CURRENT REPORT*

*PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934*

| Date of
Report (Date of earliest event reported): November 6, 2003 |
| --- |
| Anika
Therapeutics, Inc. |
| (Exact Name
of Registrant as Specified in Its Charter) |

Massachusetts	000-21326	04-3145961
(State or
Other Jurisdiction of Incorporation or Organization)	(Commission
file Number)	(I.R.S.
Employer Identification No.)
160 New Boston Street, Woburn, Massachusetts		01801
(Address of
Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (781) 932-6616

SEQ.=1,FOLIO='',FILE='C:\jms\sbalaji\03-4959-1\task40913\4959-1-be.htm',USER='sbalaji',CD='Nov 6 20:29 2003'

*ITEM 7: FINANCIAL STATEMTENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.*

*(c) Exhibits*

Exhibit 99.1 — Press Release of Anika Therapeutics, Inc. dated November 6, 2003.

*ITEM 12: RESULTS OF OPERATIONS AND FINANCIAL CONDITION.*

On November 6, 2003, Anika Therapeutics, Inc. issued a press release (“Press Release”) announcing its financial results for the third quarter of 2003. A copy of the Press Release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

Such information, including the exhibits attached hereto, shall not be deemed filed for any purpose, including for purposes of, Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 of the Exchange Act, regardless of any general incorporation language in such filing.

2

SEQ.=1,FOLIO='2',FILE='C:\jms\sbalaji\03-4959-1\task40913\4959-1-be.htm',USER='sbalaji',CD='Nov 6 20:29 2003'

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in Woburn, Massachusetts on November 7, 2003.

| /s/
Charles H. Sherwood |
| --- |
| Charles H. Sherwood, Ph.D. Chief Executive Officer and President |

3

SEQ.=1,FOLIO='3',FILE='C:\jms\sbalaji\03-4959-1\task40913\4959-1-be.htm',USER='sbalaji',CD='Nov 6 20:29 2003'

*Exhibit Index*

| Exhibit
No. | Description |
| --- | --- |
| 99.1 | Press Release of Anika Therapeutics, Inc. dated November 6, 2003 |

4

SEQ.=1,FOLIO='4',FILE='C:\jms\sbalaji\03-4959-1\task40913\4959-1-be.htm',USER='sbalaji',CD='Nov 6 20:29 2003'